| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | EGP8L81APK |
| InChI Key | UFSKUSARDNFIRC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H18F2N2O5 |
| Molecular Weight | 452.41 |
| AlogP | 4.75 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 97.75 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| STABILISER | Cystic fibrosis transmembrane conductance regulator stabiliser | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C8
|
- | 12000 | - | - | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 32000 | - | - | - | |
|
Ion channel
Other ion channel
Chloride channel
Cystic fibrosis transmembrane conductance regulator
|
2570-2600 | - | 72800 | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cystic Fibrosis | 4 | D003550 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 936727-05-8 |
| ChEBI | 90951 |
| ChEMBL | CHEMBL2103870 |
| DrugBank | DB09280 |
| DrugCentral | 5010 |
| EPA CompTox | DTXSID30239523 |
| FDA SRS | EGP8L81APK |
| Guide to Pharmacology | 7481 |
| PharmGKB | PA166114483 |
| PubChem | 16678941 |
| SureChEMBL | SCHEMBL377028 |
| ZINC | ZINC000064033452 |